The Next Case Management Conference is Scheduled for November in the Tylenol (Acetaminophen) Litigation, Parker Waichman LLP Comments

Share Article

The Tylenol multidistrict litigation was brought over allegations involving marketing sales practice issues and product liability concerns, including alleged severe liver injury and liver failure.

News Image

Parker Waichman LLP, a national law firm dedicated to representing individuals injured by drugs and medical devices comments on activity scheduled in the ongoing Tylenol litigation organized in the Eastern District of Pennsylvania. According to a Scheduling Order, the next Case Management Conference will occur on November 18th, 2014 at 10:00 a.m. The litigation is In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436 in the U.S. District Court, Eastern District of Pennsylvania.

This meeting is one of several scheduled over lawsuits brought over alleged injuries, including severe liver damage, including liver failure, associated with Tylenol use and specifically associated with the active ingredient in Tylenol, acetaminophen, despite patients appropriately following the drug’s labeling instructions. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436 in the U.S. District Court, Eastern District of Pennsylvania.)

ABC News recently highlighted a case in which one man is now on multiple medications daily following alleged acetaminophen-related liver failure in 1993. His diagnosis of acetaminophen toxicity led to a liver transplant. According to the November 5, 2014 ABC News report, the man had been taking Extra Strength Tylenol at the recommended dose for a few days to battle the symptoms of the flu.

Tylenol is among the most popularly used painkillers on the market and is sold in both over-the-counter and prescription versions in a variety of formulations for pediatric and adult patients, Parker Waichman LLP, notes.

In 2011, the U.S. Food and Drug Administration (FDA) announced that Tylenol, and other acetaminophen-containing drugs, may cause severe liver damage. The agency then issued limits on the amount of acetaminophen allowed in any medication and also mandated a Black Box warning, its most serious warning, be applied to the drug’s packaging.

Parker Waichman continues to offer free legal consultations to victims who suffered liver injury, or other injury after using Tylenol (acetaminophen). If you or a loved one suffered liver damage after taking Tylenol, please contact the firm by visiting the firm’s Acetaminophen Liver Injury page at Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
Follow us on
Visit website